Other papers submitted by: Dr Nannini Carlotta

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Nannini Carlotta

Papers published by Dr Nannini Carlotta:

Original Research

Highly-accessed

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Cantini F, Niccoli L, Cassara E, Kaloudi O, Nannini C

Biologics: Targets and Therapy 2013, 7:1-6

Published Date: 4 January 2013

Original Research

Noteworthy comment: This study demonstrates that halving the dose of adalimumab used for the treatment of psoriatic arthritis (PsA) maintains drug efficacy, reduces drug exposure risks and affords cost savings. Clinical remission was achieved in a high percentage of patients with early PsA. In contrast to patients with rheumatoid arthitis, a high proportion of PsA patients maintained remission over a long-term follow-up.

Highly-accessed

Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study

Cantini F, Niccoli L, Cassarà E, Kaloudi O, Nannini C

Biologics: Targets and Therapy 2012, 6:201-206

Published Date: 12 July 2012

Original Research

Highly-accessed

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I

Biologics: Targets and Therapy 2012, 6:5-12

Published Date: 29 December 2011